Laboratory Medicine ›› 2018, Vol. 33 ›› Issue (11): 1043-1048.DOI: 10.3969/j.issn.1673-8640.2018.011.016
• Orginal Article • Previous Articles Next Articles
SHU Jie, SHENG Huiming
Received:
2018-02-11
Online:
2018-11-30
Published:
2018-11-28
CLC Number:
SHU Jie, SHENG Huiming. Research progress in laboratory diagnosis of IgG4-related diseases[J]. Laboratory Medicine, 2018, 33(11): 1043-1048.
Add to citation manager EndNote|Ris|BibTeX
URL: https://www.shjyyx.com/EN/10.3969/j.issn.1673-8640.2018.011.016
[1] | UMEHARA H,OKAZAKI K,MASAKI Y,et al.A novel clinical entity,IgG4-related disease(IgG4RD):general concept and details[J]. Mod Rheumatol,2012,22(1):1-14. |
[2] | YOSHIDA K,TOKI F,TAKEUCHI T,et al.Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis[J]. Dig Dis Sci,1995,40(7):1561-1568. |
[3] | KAMISAWA T,FUNATA N,HAYASHI Y,et al.A new clinicopathological entity of IgG4-related autoimmune disease[J]. J Gastroenterol,2003,38(10):982-984. |
[4] | TAKAHASHI H,YAMAMOTO M,SUZUKI C,et al.The birthday of a new syndrome:IgG4-related diseases constitute a clinical entity[J]. Autoimmun Rev,2010,9(9):591-594. |
[5] | STONE J H,KHOSROSHAHI A,DESHPANDE V,et al.Recommendations for the nomenclature of IgG4-related disease and its individual organ system manifestations[J]. Arthritis Rheum,2012,64(10):3061-3067. |
[6] | NISHIMORI I,TAMAKOSHI A,OTSUKI M,et al.Prevalence of autoimmune pancreatitis in Japan from a nationwide survey in 2002[J]. J Gastroenterol,2007,42(Suppl 18):6-8. |
[7] | HUGGETT M T,CULVER E L,KUMAR M,et al.Type 1 autoimmune pancreatitis and IgG4-related sclerosing cholangitis is associated with extrapancreatic organ failure,malignancy,and mortality in a prospective UK cohort[J]. Am J Gastroenterol,2014,109(10):1675-1683. |
[8] | LANG D,ZWERINA J,PIERINGER H.IgG4-related disease:current challenges and future prospects[J]. Ther Clin Risk Manag,2016,12:189-199. |
[9] | FERNÁNDEZ-CODINA A,MARTÍNEZ-VALLE F,PINILLA B,et al. IgG4-related disease:results from a multicenter Spanish registry[J]. Medicine(Baltimore),2015,94(32):e1275. |
[10] | KAMISAWA T,ZEN Y,PILLAI S,et al.IgG4-related disease[J]. Lancet,2015,385(9976):1460-1471. |
[11] | INOUE D,YOSHIDA K,YONEDA N,et al.IgG4-related disease:dataset of 235 consecutive patients[J]. Medicine(Baltimore),2015,94(15):e680. |
[12] | KAMISAWA T,OKAZAKI K.Diagnosis and treatment of IgG4-related disease[J]. Curr Top Microbiol Immunol,2017,401:19-33. |
[13] | DIVATIA M,KIM S A,RO J Y.IgG4-related sclerosing disease,an emerging entity:a review of a multi-system disease[J]. Yonsei Med J,2012,53(1):15-34. |
[14] | MAHAJAN V S,MATTOO H,DESHPANDE V,et al.IgG4-related disease[J]. Annu Rev Pathol,2014,9:315-347. |
[15] | SASAKI T,AKIYAMA M,KANEKO Y,et al.Risk factors of relapse following glucocorticoid tapering in IgG4-related disease[J]. Clin Exp Rheumatol,2018,36 |
[Suppl 112.(3)]:186-189. | |
[16] | ZHANG L,SMYRK T C.Autoimmune pancreatitis and IgG4-related systemic diseases[J]. Int J Clin Exp Pathol,2010,3(5):491-504. |
[17] | KAMISAWA T,SHIMOSEGAWA T,OKAZAKI K,et al.Standard steroid treatment for autoimmune pancreatitis[J]. Gut,2009,58(11):1504-1507. |
[18] | CARRUTHERS M N,TOPAZIAN M D,KHOSROSHAHI A,et al.Rituximab for IgG4-related disease:a prospective,open-label trial[J]. Ann Rheum Dis,2015,74(6):1171-1177. |
[19] | TANG S H,LIN M H,DU J S,et al.IgG4-related disease with bone marrow involvement mimicking multiple myeloma[J]. Br J Haematol,2017,177(5):673. |
[20] | STONE J H,CHAN J K,DESHPANDE V,et al.IgG4-related disease[J]. Int J Rheumatol,2013,2013:532612. |
[21] | PERUGINO C A,MATTOO H,MAHAJAN V S,et al.Emerging treatment models in rheumatology:IgG4-related disease:insights into human immunology and targeted therapies[J]. Arthritis Rheumatol,2017,69(9):1722-1732. |
[22] | YAMAMOTO M,TAKAHASHI H,SHINOMURA Y.Mechanisms and assessment of IgG4-related disease:lessons for the rheumatologist[J]. Nat Rev Rheumatol,2014,10(3):148-159. |
[23] | AKIYAMA M,YASUOKA H,YOSHIMOTO K,et al.Interleukin-4 contributes to the shift of balance of IgG subclasses toward IgG4 in IgG4-related disease[J]. Cytokine,2018,110:416-419. |
[24] | FURUKAWA S,MORIYAMA M,MIYAKE K,et al.Interleukin-33 produced by M2 macrophages and other immune cells contributes to Th2 immune reaction of IgG4-related disease[J]. Sci Rep,2017,7:42413. |
[25] | 刘燕鹰,张文. 第三届国际IgG4相关性疾病和纤维化疾病研讨会纪要[J]. 中华临床免疫和变态反应杂志,2017,11(1):99-100. |
[26] | FUKUI Y,UCHIDA K,SAKAGUCHI Y,et al.Possible involvement of Toll-like receptor 7 in the development of type 1 autoimmune pancreatitis[J]. J Gastroenterol,2015,50(4):435-444. |
[27] | AKITAKE R,WATANABE T,ZAIMA C,et al.Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease[J]. Gut,2010,59(4):542-545. |
[28] | YAMAMOTO M,NAISHIRO Y,SUZUKI C,et al.Proteomics analysis in 28 patients with systemic IgG4-related plasmacytic syndrome[J]. Rheumatol Int,2010,30(4):565-568. |
[29] | ITO A,SHIMADA H,ISHIKAWA K,et al.Association between HLA-DRB1*0405,-DQB1*0401 and -DQA1*0303 alleles and lamotrigine-induced cutaneous adverse drug reactions. A pilot case-control study from Japan[J]. J Affect Disord,2015,179:47-50. |
[30] | PARK D H,KIM M H,OH H B,et al.Substitution of aspartic acid at position 57 of the DQbeta1 affects relapse of autoimmune pancreatitis[J]. Gastroenterology,2008,134(2):440-446. |
[31] | 于立杰,陈雨,张盼盼,等. IgG4相关疾病与人类白细胞抗原-DR、DQ等位基因的相关性[J]. 中华临床免疫和变态反应杂志,2016,10(4):346-350. |
[32] | LI M,ZHOU Q,YANG K,et al.Rare case of Helicobacter pylori-positive multiorgan IgG4-related disease and gastric cancer[J]. World J Gastroenterol,2015,21(11):3429-3434. |
[33] | CULVER E L,SMIT W L,EVANS C,et al.No evidence to support a role for Helicobacter pylori infection and plasminogen binding protein in autoimmune pancreatitis and IgG4-related disease in a UK cohort[J]. Pancreatology,2017,17(3):395-402. |
[34] | BLAGOVA O V,NEDOSTUP A V,SHERSTNEVA L V,et al.Takayasu's disease in an IgG4-positive patient with tuberculosis,pulmonary hemorrhage,recurrent myocarditis,and transient bilateral visual impairments[J]. Ter Arkh,2017,89(3):85-93. |
[35] | HAO M,LI W,YI L,et al.Hybrid kappa\lambda antibody is a new serological marker to diagnose autoimmune pancreatitis and differentiate it from pancreatic cancer[J]. Sci Rep,2016,6:27415. |
[36] | CULVER E L,SADLER R,SIMPSON D,et al.Elevated serum IgG4 levels in diagnosis,treatment response,organ involvement,and relapse in a prospective IgG4-related disease UK cohort[J]. Am J Gastroenterol,2016,111(5):733-743. |
[37] | DESHPANDE V,ZEN Y,CHAN J K,et al.Consensus statement on the pathology of IgG4-related disease[J]. Mod Pathol,2012,25(9):1181-1192. |
[38] | MARTÍNEZ-VALLE F,FERNÁNDEZ-CODINA A,PINAL-FERNÁNDEZ I,et al. IgG4-related disease:evidence from six recent cohorts[J]. Autoimmun Rev,2017,16(2):168-172. |
[39] | YU K H,CHAN T M,TSAI P H,et al.Diagnostic performance of serum IgG4 levels in patients with IgG4-related disease[J]. Medicine(Baltimore),2015,94(41):e1707. |
[40] | MASAKI Y,KUROSE N,YAMAMOTO M,et al.Cutoff values of serum IgG4 and histopathological IgG4+ plasma cells for diagnosis of patients with IgG4-related disease[J]. Int J Rheumatol,2012,2012:580814. |
[41] | LIN W,ZHANG P,CHEN H,et al.Circulating plasmablasts/plasma cells:a potential biomarker for IgG4-related disease[J]. Arthritis Res Ther,2017,19(1):25. |
[42] | WALLACE Z S,DESHPANDE V,MATTOO H,et al.IgG4-related disease:clinical and laboratory features in one hundred twenty-five patients[J]. Arthritis Rheumatol,2015,67(9):2466-2475. |
[43] | CARRUTHERS M N,KHOSROSHAHI A,AUGUSTIN T,et al.The diagnostic utility of serum IgG4 concentrations in IgG4-related disease[J]. Ann Rheum Dis,2015,74(1):14-18. |
[1] | LUO Ting, PAN Xiujun. Research progress on neutrophil extracellular traps in ulcerative colitis [J]. Laboratory Medicine, 2020, 35(6): 626-630. |
[2] | YU Xiaochun, HU Xujiao, ZHANG Jiaqing, GUO Leilei. Roles of HA,Ⅳ-C,APRI and Fib-4 in the diagnosis of hepatitis B-related liver fibrosis [J]. Laboratory Medicine, 2019, 34(6): 539-542. |
[3] | HOU Li, YU Lu, NIU Yao, ZHANG Yuan, WANG Liang. Role of noninvasive diagnostic model for liver fibrosis in patients with chronic hepatitis B [J]. Laboratory Medicine, 2018, 33(10): 888-893. |
[4] | CHEN Shuimian, YU Chongzhao, LI Enling, ZHU Haoming, LU Jingbo, ZHENG Bing. Autoantibody-related parameters in patients with autoimmune diseases and healthy subjects [J]. Laboratory Medicine, 2018, 33(1): 31-36. |
[5] | TAN Liming, DING Yaodong, CHEN Juanjuan, LI Hua, JIANG Yongqing, WAN Yani, WANG Liyun, WANG Tian. Complement 1q determination for autoimmune diseases [J]. Laboratory Medicine, 2017, 32(8): 686-690. |
[6] | ZHOU Xinyun, CHEN Hui, SHEN Lisong. Research progress on the new types of autoantibodies in autoimmune diseases [J]. Laboratory Medicine, 2017, 32(6): 543-548. |
[7] | ZHOU Xinyun, CHEN Hui, SHEN Lisong. Research progress on the new types of autoantibodies in autoimmune diseases [J]. Laboratory Medicine, 2017, 32(6): 543-548. |
[8] | ZHOU Lin, JIANG Li, FAN Yupeng, LU Xunqiang, ZHU Yanzhong, SHENG Zhenhai. Nonalcoholic fatty liver disease and serum CK -18 and liver fibrosis index correlation analysis [J]. Laboratory Medicine, 2016, 31(2): 99-102. |
[9] | LI Shengjie, ZHANG Aiping, CAO Wenjun. Complement deficiency and its associated diseases [J]. Laboratory Medicine, 2015, 30(2): 195-200. |
[10] | SONG Hui, LIU Xinghui, SHEN Zhenhua, CHEN Qing, XU Fengxia, XU Limin. Research on the clinical significance of CTHRC1 for HBV [J]. Laboratory Medicine, 2015, 30(11): 1104-1106. |
[11] | YANG Jingjing,JIANG Hongmin,TANG Aiguo.. The significance of fibronectin detection in hepatofibrosis [J]. , 2014, 29(4): 331-336. |
[12] | WANG Fengyuan, ZHANG Linhua, LAI Weiqiang. The significance of the combined detection of AFP and ferritin with serum hepatic fibrosis indices in Child-Pugh classification among patients with liver cirrhosis [J]. , 2014, 29(12): 1222-1225. |
[13] | QIAN Niandong, HUANG Ping, QI Jin, DENG Lianfu.. Correlation analysis of serum osteopontin and liver fibrosis in non-alcoholic fatty liver disease patients [J]. , 2014, 29(11): 1154-1157. |
[14] | LI Linyun. Preliminary investigation on the clinical significance of anticytoplasmic autoantibodies [J]. , 2013, 28(2): 120-123. |
[15] | RUAN Shuiliang;LIU Dexu;WANG Bo;BI Jun;JI Xia;WU Jun;DU Yingyuan. The relationship between serum insulin-like growth factor-1 and liver function in patients with schistosomal liver fibrosis [J]. , 2010, 25(01): 17-20. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||